idarubicin has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iland, HJ; Mohamed, M; Sharma, S; Supple, SG | 1 |
| Bell, D; Dalley, D; Levi, J; Presgrave, P; Woods, R | 1 |
2 other study(ies) available for idarubicin and Colorectal Cancer
| Article | Year |
|---|---|
Atypical presentation of therapy-related acute promyelocytic leukaemia with marrow fibrosis.
Topics: Acute Disease; Adenocarcinoma; Antineoplastic Agents; Capecitabine; Chemoradiotherapy; Colorectal Neoplasms; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Middle Aged; Neoplasms, Second Primary; Organoplatinum Compounds; Oxaliplatin; Pancytopenia; Primary Myelofibrosis; Remission Induction; Tretinoin | 2016 |
A phase II trial of oral 4'demethoxydaunorubicin in advanced colorectal carcinoma.
Topics: Administration, Oral; Aged; Colorectal Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Idarubicin; Leukopenia; Male; Middle Aged | 1988 |